Prosight Management, LP - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 5 filers reported holding ALBIREO PHARMA INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$10,518,149
+10.6%
486,726
-0.9%
5.74%
+12.6%
Q3 2022$9,510,000
+2.4%
491,244
+5.0%
5.10%
-30.4%
Q2 2022$9,290,000
-35.1%
467,795
-2.5%
7.32%
-20.8%
Q1 2022$14,318,000
+19.6%
480,000
-6.6%
9.25%
+29.0%
Q4 2021$11,973,000
-13.8%
514,082
+15.5%
7.17%
-6.2%
Q3 2021$13,885,000
+33.8%
445,020
+50.8%
7.64%
+17.7%
Q2 2021$10,381,000
+72.9%
295,080
+73.2%
6.49%
+32.0%
Q1 2021$6,005,000
-8.4%
170,352
-2.5%
4.92%
+62.3%
Q4 2020$6,556,000
+60.4%
174,791
+42.7%
3.03%
+55.8%
Q3 2020$4,088,000
-22.4%
122,500
-38.4%
1.94%
-14.0%
Q2 2020$5,266,000
-2.6%
198,800
-39.8%
2.26%
-10.6%
Q1 2020$5,409,000
-13.9%
330,407
+33.7%
2.53%
-8.4%
Q4 2019$6,283,000
+24.4%
247,178
-2.1%
2.76%
-1.5%
Q3 2019$5,050,000
-38.2%
252,500
-0.3%
2.80%
-32.0%
Q2 2019$8,167,000
-6.0%
253,327
-6.1%
4.12%
+8.3%
Q1 2019$8,691,000
+31.1%
269,836
-0.1%
3.80%
+11.2%
Q4 2018$6,627,000
+23.4%
270,146
+65.8%
3.42%
+14.3%
Q3 2018$5,369,000162,9052.99%
Other shareholders
ALBIREO PHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Prosight Management, LP 514,082$11,973,0007.17%
Privium Fund Management B.V. 379,117$8,959,0001.78%
Birchview Capital, LP 113,000$2,632,0001.70%
Sio Capital Management, LLC 213,913$4,982,0001.50%
Perceptive Advisors 4,720,278$109,936,0000.85%
Chicago Capital, LLC 849,239$19,779,0000.74%
APOGEM CAPITAL LLC 38,601$899,0000.59%
Samsara BioCapital, LLC 100,000$2,329,0000.45%
Artal Group S.A. 600,000$13,974,0000.38%
RICE HALL JAMES & ASSOCIATES, LLC 458,011$10,667,0000.38%
View complete list of ALBIREO PHARMA INC shareholders